Global Graves Orbitopathy Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

01/giu/2018 15:16:23 SAI Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Graves Orbitopathy Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024


Global Graves Orbitopathy Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024


Graves’ ophthalmopathy is also called as thyroid-associated orbitopathy (TAO) and thyroid eye disease (TED), Graves’ orbitopathy (GO) is autoimmune inflammatory disorder of the tissues of periorbit and orbit that is characterized by the retraction of upper eyelid, lagging, swelling and redness of lid, bulging of eyes and conjunctivitis. Most commonly occurs in the individuals having Graves’ disease, and less commonly in the individuals having Hashimoto’s thyroiditis, or in the people with euthyroid. It is a part of systemic process of variable expression in skin, thyroid and eyes that is caused by the autoantibodies which binds to the tissues of these organs. Autoantibodies targets the fibroblasts in the eye muscles and fibroblasts can be differentiated into the fat cells (adipocytes). Muscles and fat cells expands and gets inflammation.


Increase in incidence and prevalence of thyroid disorders, availability of appreciative reimbursement policies for the treatment, and growing awareness regarding the complications related to thyroid disorders are some of the factors driving Graves’ disease market. Side effects associated with drugs are one of the restraints for the graves orbitopathy market.


A sample of this report is available upon request @



The global graves orbitopathy market is segmented on the basis of drug class, distribution channel and geographical regions.


Based on the drug class, the graves orbitopathy market is segmented as:

·         Iodine and Iodides

·         Ionic Inhibitors

·         Radioactive Iodine

·         Beta Blockers

·         Thioamides

·         Corticosteroids


Based on the distribution channel, the graves orbitopathy market is segmented as:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Others


To view TOC of this report is available upon request @



As per Wickham study in England, in 2016, Graves’ disease is accounted for 0.5 cases per 1000 persons, with high incidence rate in people with age of 40 to 60. Graves’ disease is the high prevalent autoimmune disorder in U.S After Hashimoto thyroiditis. In 2016, as per research study of PREGO (presentation of Graves orbitopathy), incidence of Graves’ orbitopathy in Europe was 10-30/10,000 human annually. However, severity and the incidence of the Graves’ disease in Europe was observed to decline to 2.10/10,000/year. Iodine-131 is used in radioactive iodine ablation (RIA) used to remove whole or a part of thyroid gland, which results in preventing the excessive production of thyroid hormone. Subtotal thyroidectomy used for the removal of thyroid gland is the most invasive treatment option.


Need more information about this report @




On the basis of geographical regions, the graves’ orbitopathy market is segmented as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected as major market for the disorders related to thyroid gland followed by Europe. Asia-Pacific is expected to be as a rapidly growing market due to rise in thyroid gland disorders, rise in health care investments, growing awareness regarding hyperthyroidism, and different alternative treatments availability.


Some of the players in the graves orbitopathy disease market are GlaxoSmithKline plc (U.K.), Allergan, plc.(Ireland) Abbott Laboratories (U.S.) RLC LABS (U.S.), AbbVie, Inc.( U.S.), Mylan N.V.( U.S.), Pfizer, Inc. (U.S.), and Merck & Co.,Inc. (U.S.).


Get access to full summary @


About Precision Business Insights


Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.


Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.


Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights



Contact to Precision Business Insights,


Kemp House,


152 – 160 City Road,


London EC1V 2NX




Toll Free (US): +1-866-598-1553

Website @

blog comments powered by Disqus è un servizio offerto da Factotum Srl